EHS Management Measures

Sustainability and Environment policy

Under the trend of the global net-zero goal by 2050, energy-saving and carbon-reduction have become one of the important goals of every enterprise.
Bora Group is actively developing energy-saving and carbon-reduction measures to reduce the impact of climate change. It plans to promote the ISO-14001 environmental management system from 2025 and strives to achieve environmentally friendly and sustainable development, and formulate the group’s environmental safety and health policy to practice top-to-bottom management.

In accordance with the requirements of ISO-14064 Greenhouse Gas Inventory System, the following policies have been established:

 

  • Implement the carbon inventory mechanism and disclose the carbon emissions status of each subsidiary
  • Through the carbon inventory system, identify opportunities for reduction in internal and external activities of the enterprise
  • For consumers and customers, aim to implement a green supply chain
  • Consider the carbon footprint of the product’s life cycle, from raw materials to use to disposal.

Our Goals

  • 2025-2030 Short-term goals:Bora will plan to purchase green electricity or other renewable energy and uses 2023 as the base year and by 2030, the goal is to reduce Scope-1 and Scope-2 carbon emissions by 30% by 2030. In 2025, we plan promote the inventory of purchasing goods and services in the entire group and complete the report. In 2026, in 2025 we will promote ISO-50001 certification.
  • 2031-2040 Mid-term goals:During this 10-year period, we will continue to identify opportunities to reduce carbon emissions by 42% in Scope-1 and Scope-2, and reduce carbon emissions from purchasing goods and services in Scope-3 by 25%.
  • 2041-2050 Long-term goals:Bora aims to achieve net-zero emissions by 2050 and achieve net-zero emissions for the entire group.

Our Environmental Commitment and Achievements

Bora Pharmaceutical values environmental protection and reports regularly to the Board to ensure management engagement. We actively communicate with stakeholders to prevent negative impacts and continuously monitor environmental metrics at each facility. On November 13, 2024, the Board meeting included the presentation of our 2025 greenhouse gas inventory and verification plan, alongside the 2024 execution progress and quantitative targets for the following year for each facility, underscoring our commitment to environmental sustainability.

Energy management

Bora Group has introduced the ISO 14064-1:2006 greenhouse gas, GHG inventory mechanism in 2021, and appointed a third-party organization to conduct greenhouse gas inventory assurance operations in 2023. It has obtained a GHG inventory assurance report in July 2024. In the future, the GHG emissions will based on in 2023 are used as the base year for GHG reduction.

Water resources management

In recent years, climate change has intensified, often leading to water shortages, which has increased stakeholder concerns about water resource issues. Water scarcity is a global challenge that we all face. Bora Pharmaceuticals aims to minimize its water demand and potential impacts by promoting daily water-saving measures, reducing the environmental demands of its processes, and partially recycling water. According to the water risk assessment tool Aqueduct, developed by the World Resources Institute (WRI), Taiwan’s plants are facing low to medium risk, while the Canada plant is at medium to high risk. To mitigate the risk of water shortages that may be caused by climate change, Bora Pharmaceuticals will continue to review its water usage and monitor potential water shortage risks while evaluating strategies to improve water use efficiency.

Water management

Bora Pharmaceuticals follows the Waste Disposal Act to collect, classify, and store waste, and conducts online reporting as required. Qualified contractors are commissioned to remove and treat the waste. After removal, it is confirmed according to regulations that the waste has been received by the remover and the processor before final transportation confirmation is completed.

Making Success More Certain

Our team is here to discuss how we can become a trusted partner to help bring your breakthrough drug successfully to market.